交易 Roche Holding AG - ROGz CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
| 价差 | 1.1 | ||||||||
|
多头隔夜费
Long position overnight fee
前往平台 | -0.014885% | ||||||||
|
空头隔夜费
Short position overnight fee
前往平台 | -0.007337% | ||||||||
| 隔夜费时间 | 21:00 (UTC) | ||||||||
| 最小交易量 | 1 | ||||||||
| 货币 | CHF | ||||||||
| 保证金 | 20% | ||||||||
| 上市交易所 | Switzerland | ||||||||
| 交易费 | 0% |
*Information provided by Capital.com
Roche Holding AG ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
|---|---|---|---|---|---|---|
| May 26, 2023 | 290.7 | 1.6 | 0.55% | 289.1 | 291.2 | 286.7 |
| May 25, 2023 | 287.4 | 0.8 | 0.28% | 286.6 | 288.7 | 285.9 |
| May 24, 2023 | 288.2 | 1.2 | 0.42% | 287.0 | 288.8 | 286.3 |
| May 23, 2023 | 285.8 | 0.4 | 0.14% | 285.4 | 287.8 | 284.5 |
| May 22, 2023 | 285.7 | -1.8 | -0.63% | 287.5 | 288.4 | 283.9 |
| May 19, 2023 | 287.1 | 2.1 | 0.74% | 285.0 | 288.7 | 283.9 |
| May 17, 2023 | 283.5 | 1.4 | 0.50% | 282.1 | 284.5 | 281.9 |
| May 16, 2023 | 281.6 | -1.7 | -0.60% | 283.3 | 284.0 | 280.8 |
| May 15, 2023 | 284.2 | -0.7 | -0.25% | 284.9 | 285.5 | 283.1 |
| May 12, 2023 | 283.9 | 2.0 | 0.71% | 281.9 | 284.9 | 281.9 |
| May 11, 2023 | 281.5 | 1.0 | 0.36% | 280.5 | 283.1 | 280.4 |
| May 10, 2023 | 280.2 | -1.8 | -0.64% | 282.0 | 282.0 | 278.8 |
| May 9, 2023 | 282.9 | -1.1 | -0.39% | 284.0 | 284.5 | 281.0 |
| May 8, 2023 | 283.7 | 0.3 | 0.11% | 283.4 | 285.0 | 282.8 |
| May 5, 2023 | 282.8 | 1.4 | 0.50% | 281.4 | 282.9 | 279.9 |
| May 4, 2023 | 281.4 | 1.9 | 0.68% | 279.5 | 281.6 | 278.8 |
| May 3, 2023 | 280.4 | -0.4 | -0.14% | 280.8 | 281.2 | 277.1 |
| May 2, 2023 | 279.9 | -3.0 | -1.06% | 282.9 | 283.0 | 279.4 |
| Apr 28, 2023 | 280.2 | 3.8 | 1.37% | 276.4 | 281.0 | 275.8 |
| Apr 27, 2023 | 274.9 | -0.6 | -0.22% | 275.5 | 278.8 | 274.7 |
Roche Holding AG Events
| 时间（协调世界时） (UTC) | 国家/地区 | 事件 |
|---|---|---|
| Wednesday, May 31, 2023 | ||
| 时间（协调世界时） (UTC) 12:00 | 国家/地区 CH
| 事件 Roche Holding AG at Sanford C Bernstein Strategic Decisions Conference Roche Holding AG at Sanford C Bernstein Strategic Decisions ConferenceForecast -Previous - |
| Wednesday, June 7, 2023 | ||
| 时间（协调世界时） (UTC) 12:00 | 国家/地区 CH
| 事件 Roche Holding AG at Jefferies Healthcare Conference Roche Holding AG at Jefferies Healthcare ConferenceForecast -Previous - |
| Thursday, June 8, 2023 | ||
| 时间（协调世界时） (UTC) 06:00 | 国家/地区 CH
| 事件 Roche Holding AG at Exane CEO Conference Roche Holding AG at Exane CEO ConferenceForecast -Previous - |
| Monday, June 12, 2023 | ||
| 时间（协调世界时） (UTC) 14:30 | 国家/地区 CH
| 事件 Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and NephrologyForecast -Previous - |
| Wednesday, June 14, 2023 | ||
| 时间（协调世界时） (UTC) 12:00 | 国家/地区 CH
| 事件 Roche Holding AG at Stifel Swiss Equities Conference Roche Holding AG at Stifel Swiss Equities ConferenceForecast -Previous - |
| 时间（协调世界时） (UTC) 15:00 | 国家/地区 CH
| 事件 Roche Holding AG at Goldman Sachs Healthcare Conference Roche Holding AG at Goldman Sachs Healthcare ConferenceForecast -Previous - |
| Tuesday, June 20, 2023 | ||
| 时间（协调世界时） (UTC) 07:00 | 国家/地区 CH
| 事件 Roche Holding AG at Citi European Healthcare Conference Roche Holding AG at Citi European Healthcare ConferenceForecast -Previous - |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 总收入 | 63281 | 62801 | 58323 | 61466 | 56846 |
| 收入 | 63281 | 62801 | 58323 | 61466 | 56846 |
| 收入成本，共计 | 18511 | 19348 | 15900 | 17377 | 16445 |
| 毛利 | 44770 | 43453 | 42423 | 44089 | 40401 |
| 总营业费用 | 45805 | 44646 | 39780 | 43918 | 42077 |
| 销售/一般/行政费用，总计 | 12124 | 12100 | 12075 | 13208 | 12453 |
| 研究与开发 | 14050 | 13707 | 12151 | 11690 | 11048 |
| Depreciation / Amortization | 378 | 351 | 446 | 268 | 183 |
| 异常费用（收入） | 2569 | 376 | 426 | 2677 | 3945 |
| Other Operating Expenses, Total | -1827 | -1236 | -1218 | -1302 | -1997 |
| 营业收入 | 17476 | 18155 | 18543 | 17548 | 14769 |
| 利息收入（费用），非经营净值 | -1040 | -677 | -463 | -758 | -419 |
| 其他，净值 | -109 | -80 | -115 | -176 | -202 |
| 税前净收入 | 16327 | 17398 | 17965 | 16614 | 14148 |
| 税后净收入 | 13531 | 14935 | 15068 | 14108 | 10830 |
| 少数股东权益 | -1110 | -1005 | -773 | -611 | -365 |
| 未计算非常项目前的净收益 | 12421 | 13930 | 14295 | 13497 | 10465 |
| 净收入 | 12421 | 13930 | 14295 | 13497 | 10500 |
| 普通股股东可获收益 (不含非经常性项目) | 12421 | 13930 | 14295 | 13497 | 10465 |
| 普通股股东可获收益 (含非經常性項目) | 12421 | 13930 | 14295 | 13497 | 10500 |
| 摊薄调整 | -1 | -1 | -1 | -2 | -1 |
| 摊薄净收入 | 12420 | 13929 | 14294 | 13495 | 10499 |
| 摊薄后加权平均股 | 808 | 860 | 865 | 864 | 860 |
| 扣除特别项目的每股摊薄盈利 | 15.3713 | 16.1965 | 16.5249 | 15.6192 | 12.1674 |
| Dividends per Share - Common Stock Primary Issue | 9.5 | 9.3 | 9.1 | 9 | 8.7 |
| 每股正常摊薄盈利 | 17.9847 | 16.5778 | 16.9515 | 18.2807 | 15.702 |
| 非常规项目总计 | 35 |
| Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
|---|---|---|---|---|
| 总收入 | 30986 | 32295 | 32088 | 30713 |
| 收入 | 30986 | 32295 | 32088 | 30713 |
| 收入成本，共计 | 8949 | 9562 | 10279 | 9069 |
| 毛利 | 22037 | 22733 | 21809 | 21644 |
| 总营业费用 | 25057 | 20748 | 24010 | 20636 |
| 销售/一般/行政费用，总计 | 6479 | 5645 | 6544 | 5556 |
| 研究与开发 | 7422 | 6628 | 7017 | 6690 |
| Depreciation / Amortization | 196 | 182 | 177 | 174 |
| 异常费用（收入） | 2584 | -15 | 619 | -243 |
| Other Operating Expenses, Total | -573 | -1254 | -626 | -610 |
| 营业收入 | 5929 | 11547 | 8078 | 10077 |
| 利息收入（费用），非经营净值 | -568 | -472 | -524 | -151 |
| 其他，净值 | -19 | -90 | -43 | -39 |
| 税前净收入 | 5342 | 10985 | 7511 | 9887 |
| 税后净收入 | 4370 | 9161 | 6719 | 8216 |
| 少数股东权益 | -479 | -631 | -592 | -413 |
| 未计算非常项目前的净收益 | 3891 | 8530 | 6127 | 7803 |
| 净收入 | 3891 | 8530 | 6127 | 7803 |
| 普通股股东可获收益 (不含非经常性项目) | 3891 | 8530 | 6127 | 7803 |
| 普通股股东可获收益 (含非經常性項目) | 3891 | 8530 | 6127 | 7803 |
| 摊薄调整 | -1 | 0 | -1 | 0 |
| 摊薄净收入 | 3890 | 8530 | 6126 | 7803 |
| 摊薄后加权平均股 | 806 | 810 | 858 | 862 |
| 扣除特别项目的每股摊薄盈利 | 4.8263 | 10.5309 | 7.13986 | 9.0522 |
| Dividends per Share - Common Stock Primary Issue | 9.5 | 0 | 9.3 | 0 |
| 每股正常摊薄盈利 | 7.42355 | 10.5195 | 7.78732 | 8.8218 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 流动资产总额 | 33816 | 35627 | 32942 | 31254 | 32244 |
| 现金和短期投资 | 9767 | 13031 | 12334 | 11858 | 13118 |
| Cash | 2841 | 5028 | 4536 | 4769 | 4139 |
| 现金等价物 | 2150 | 1822 | 1191 | 1306 | 2542 |
| 短期投资 | 4776 | 6181 | 6607 | 5783 | 6437 |
| 应收账款总额，净额 | 13866 | 12651 | 11740 | 12150 | 11487 |
| Accounts Receivable - Trade, Net | 11527 | 10719 | 10056 | 10343 | 9687 |
| Total Inventory | 8605 | 7715 | 7194 | 6055 | 6621 |
| Prepaid Expenses | 1202 | 1869 | 1153 | 795 | 683 |
| Other Current Assets, Total | 376 | 361 | 521 | 396 | 335 |
| Total Assets | 88151 | 92317 | 86138 | 83091 | 78517 |
| Property/Plant/Equipment, Total - Net | 24208 | 24412 | 23270 | 23318 | 21818 |
| Property/Plant/Equipment, Total - Gross | 49408 | 48205 | 45664 | 45041 | 41822 |
| Accumulated Depreciation, Total | -25200 | -23793 | -22394 | -21723 | -20004 |
| Goodwill, Net | 10820 | 10809 | 9249 | 12456 | 8948 |
| Intangibles, Net | 9685 | 12117 | 12017 | 8358 | 9346 |
| Long Term Investments | 971 | 1069 | 1276 | 739 | 602 |
| Note Receivable - Long Term | 125 | 133 | 125 | 128 | 132 |
| Other Long Term Assets, Total | 8526 | 8150 | 7259 | 6838 | 5427 |
| Total Current Liabilities | 27239 | 38416 | 25401 | 24119 | 23033 |
| Accounts Payable | 3861 | 3844 | 3317 | 3176 | 2847 |
| Accrued Expenses | 12180 | 12497 | 11205 | 11214 | 10676 |
| Notes Payable/Short Term Debt | 2191 | 14618 | 2189 | 1694 | 722 |
| Current Port. of LT Debt/Capital Leases | 2071 | 833 | 2126 | 341 | 1971 |
| Other Current Liabilities, Total | 6936 | 6624 | 6564 | 7694 | 6817 |
| Total Liabilities | 60159 | 67828 | 49797 | 50344 | 50895 |
| Total Long Term Debt | 22282 | 17101 | 11096 | 13547 | 16077 |
| Long Term Debt | 21391 | 16076 | 10220 | 12668 | 16075 |
| Capital Lease Obligations | 891 | 1025 | 876 | 879 | 2 |
| Deferred Income Tax | 645 | 628 | 353 | 298 | 384 |
| Minority Interest | 4023 | 3856 | 3432 | 3120 | 2744 |
| Other Liabilities, Total | 5970 | 7827 | 9515 | 9260 | 8657 |
| Total Equity | 27992 | 24489 | 36341 | 32747 | 27622 |
| Common Stock | 107 | 160 | 160 | 160 | 160 |
| Retained Earnings (Accumulated Deficit) | 38937 | 34161 | 45571 | 40524 | 34935 |
| Unrealized Gain (Loss) | -59 | -60 | 106 | 15 | 28 |
| Other Equity, Total | -10993 | -9772 | -9496 | -7952 | -7501 |
| Total Liabilities & Shareholders’ Equity | 88151 | 92317 | 86138 | 83091 | 78517 |
| Total Common Shares Outstanding | 799.181 | 800.403 | 853.126 | 855.756 | 854.428 |
| Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
|---|---|---|---|---|
| 流动资产总额 | 33816 | 30321 | 35627 | 31260 |
| 现金和短期投资 | 9767 | 6808 | 13031 | 8017 |
| 现金等价物 | 4991 | 4315 | 6850 | 5000 |
| 短期投资 | 4776 | 2493 | 6181 | 3017 |
| 应收账款总额，净额 | 11919 | 11078 | 11126 | 11809 |
| Accounts Receivable - Trade, Net | 11606 | 10809 | 10806 | 11656 |
| Total Inventory | 8605 | 8292 | 7715 | 8319 |
| Other Current Assets, Total | 3525 | 4143 | 3755 | 3115 |
| Total Assets | 88151 | 86736 | 92317 | 87887 |
| Property/Plant/Equipment, Total - Net | 24208 | 24324 | 24412 | 24300 |
| Goodwill, Net | 10820 | 11160 | 10809 | 10623 |
| Intangibles, Net | 9685 | 11735 | 12117 | 12510 |
| Other Long Term Assets, Total | 9622 | 9196 | 9352 | 9194 |
| Total Current Liabilities | 27239 | 27409 | 38416 | 25193 |
| Payable/Accrued | 4556 | 3896 | 4637 | 4241 |
| Notes Payable/Short Term Debt | 2191 | 2976 | 14618 | 2530 |
| Current Port. of LT Debt/Capital Leases | 1769 | 2405 | 504 | 1196 |
| Other Current Liabilities, Total | 18723 | 18132 | 18657 | 17226 |
| Total Liabilities | 60159 | 61547 | 67828 | 50073 |
| Total Long Term Debt | 21391 | 22369 | 16076 | 11285 |
| Long Term Debt | 21391 | 22369 | 16076 | 11285 |
| Deferred Income Tax | 645 | 690 | 628 | 499 |
| Minority Interest | 4023 | 3757 | 3856 | 3619 |
| Other Liabilities, Total | 6861 | 7322 | 8852 | 9477 |
| Total Equity | 27992 | 25189 | 24489 | 37814 |
| Common Stock | 107 | 107 | 160 | 160 |
| Retained Earnings (Accumulated Deficit) | 38937 | 35740 | 34161 | 46686 |
| Unrealized Gain (Loss) | -59 | -151 | -60 | -90 |
| Other Equity, Total | -10993 | -10507 | -9772 | -8942 |
| Total Liabilities & Shareholders’ Equity | 88151 | 86736 | 92317 | 87887 |
| Total Common Shares Outstanding | 799.181 | 800.579 | 800.403 | 854.261 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 净收入/起跑线 | 13531 | 14935 | 15068 | 14108 | 10865 |
| 经营活动产生的现金 | 18415 | 20976 | 18566 | 22385 | 19979 |
| 经营活动产生的现金 | 2906 | 2887 | 2808 | 2760 | 2292 |
| Amortization | 938 | 1556 | 1750 | 1532 | 1294 |
| 非现金物品 | 9267 | 7718 | 6227 | 8883 | 10308 |
| Cash Taxes Paid | 4102 | 3343 | 3236 | 3543 | 3288 |
| 已付现金利息 | 557 | 407 | 422 | 624 | 593 |
| 营运资金的变化 | -8227 | -6120 | -7287 | -4898 | -4780 |
| 投资活动产生的现金 | -3536 | -6552 | -9067 | -8634 | -7195 |
| 资本支出 | -4797 | -4652 | -7858 | -4896 | -6746 |
| 其他投资现金流量项目，总计 | 1261 | -1900 | -1209 | -3738 | -449 |
| 融资活动产生的现金 | -16275 | -13108 | -9666 | -14173 | -10691 |
| 融资现金流项目 | -2340 | -2333 | -1992 | -1716 | -3316 |
| Total Cash Dividends Paid | -7832 | -8132 | -7964 | -7682 | -7253 |
| 债务的发行（退还），净额 | -6103 | 16348 | 290 | -4775 | -122 |
| 外汇效应 | -463 | -193 | -181 | -184 | -131 |
| 现金净变化 | -1859 | 1123 | -348 | -606 | 1962 |
| 股票的发行（报废），净额 | 0 | -18991 |
| Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
|---|---|---|---|---|
| Net income/Starting Line | 13531 | 9161 | 14935 | 8216 |
| Cash From Operating Activities | 18415 | 9509 | 20976 | 8212 |
| Cash From Operating Activities | 2906 | 1429 | 2887 | 1439 |
| Amortization | 938 | 471 | 1556 | 830 |
| Non-Cash Items | 9267 | 3799 | 7718 | 3323 |
| Cash Taxes Paid | 4102 | 2482 | 3343 | 2183 |
| Cash Interest Paid | 557 | 228 | 407 | 243 |
| Changes in Working Capital | -8227 | -5351 | -6120 | -5596 |
| Cash From Investing Activities | -3536 | 1473 | -6552 | 44 |
| Capital Expenditures | -4797 | -2067 | -4652 | -2197 |
| Other Investing Cash Flow Items, Total | 1261 | 3540 | -1900 | 2241 |
| Cash From Financing Activities | -16275 | -13315 | -13108 | -9056 |
| Financing Cash Flow Items | -2340 | -1374 | -2333 | -1211 |
| Total Cash Dividends Paid | -7832 | -7672 | -8132 | -7955 |
| Issuance (Retirement) of Debt, Net | -6103 | -4269 | 16348 | 110 |
| Foreign Exchange Effects | -463 | -202 | -193 | 73 |
| Net Change in Cash | -1859 | -2535 | 1123 | -727 |
| Issuance (Retirement) of Stock, Net | 0 | -18991 |
| 投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.1079 | 21834628 | 173085 | 2023-04-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.8532 | 20045265 | 2208289 | 2022-12-31 | LOW |
| UBS Asset Management (Switzerland) | Investment Advisor | 1.8605 | 13071428 | -86601 | 2023-04-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8316 | 12868041 | 71688 | 2023-04-30 | LOW |
| Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 1.667 | 11711936 | 8879 | 2023-04-30 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 1.5309 | 10755461 | 141764 | 2023-04-30 | LOW |
| Zürcher Kantonalbank (Asset Management) | Bank and Trust | 1.239 | 8704542 | 83328 | 2023-04-30 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.9971 | 7005557 | -46636 | 2023-04-30 | LOW |
| Fidelity International | Investment Advisor | 0.8201 | 5761424 | 114439 | 2023-03-31 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.6721 | 4722004 | 7988 | 2023-04-30 | LOW |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.6581 | 4623374 | -19085 | 2023-03-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.6181 | 4342654 | -1572740 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6015 | 4226034 | 30 | 2023-04-30 | LOW |
| Dodge & Cox | Investment Advisor/Hedge Fund | 0.5908 | 4150400 | 75100 | 2023-03-31 | LOW |
| California Public Employees' Retirement System | Pension Fund | 0.5839 | 4102151 | -453583 | 2022-06-30 | LOW |
| Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.5297 | 3721580 | -1515868 | 2023-04-30 | MED |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5147 | 3616071 | -2492 | 2023-04-30 | LOW |
| RBC Global Asset Management (UK) Limited | Investment Advisor | 0.4154 | 2918253 | -77338 | 2023-04-30 | LOW |
| PRIMECAP Management Company | Investment Advisor | 0.3704 | 2602358 | -25668 | 2023-03-31 | LOW |
| Mawer Investment Management Ltd. | Investment Advisor | 0.3591 | 2522750 | 367 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投资
交易规模（杠杆 x 投资）：
開倉
平仓
做空 做多
Roche Company profile
关于 Roche Holding AG
罗氏控股股份公司（Roche）是一家以研究为基础的医疗保健公司。 公司的经营业务分为两个部门。 制药部和诊断部。 制药部门由两个业务部门组成。 罗氏制药和中外制药。 诊断学部门由四个业务领域组成。 糖尿病护理、分子诊断、专业诊断和组织诊断。 公司为各种疾病领域开发药品，包括肿瘤学、免疫学、传染病、眼科和神经科学。 公司的药品包括Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin 和 Roferon-A。 公司为研究人员提供产品，包括细胞分析、基因表达、基因组测序和核酸纯化。
| Industry: | Pharmaceuticals (NEC) |
Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗？
加入成为全球530,000万多名交易者的一份子，选择利用Capital.com进行交易吧。